Lexicon Pharmaceuticals LXRX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating cash flow?
- Lexicon Pharmaceuticals (LXRX) reported operating cash flow of -$14.73M in Q1 2026.
- How has Lexicon Pharmaceuticals's operating cash flow changed year-over-year?
- Lexicon Pharmaceuticals's operating cash flow increased by 66.4% year-over-year, from -$43.78M to -$14.73M.
- What is the long-term trend for Lexicon Pharmaceuticals's operating cash flow?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's operating cash flow has grown at a 27.1% compound annual growth rate (CAGR), from -$87.02M to -$178.78M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.